Delivery Order SPE2DB20D2104-SPE2DB26FMAAF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $29,812.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 29, 2025, with completion expected by September 30, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10,377.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). The award, issued without a set-aside designation, reflects open competition and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. Performance will be completed by July 15, 2025, with fulfillment based at the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $9,512.14 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity 8) under a firm fixed price contract. The award was made on June 30, 2025, with an ultimate completion date of July 1, 2025. This non-set-aside award represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio supporting federal medical procurement. The place of performance is listed as Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $25,574.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8 count). This non-competed delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item fulfillment under the company's existing contract vehicle with DLA. This delivery order...
- The Defense Logistics Agency awarded a $5,520.01 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count supply) on September 16, 2025, with completion expected by September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a $19,742.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a $11.89K delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This competitively awarded, firm fixed-price delivery order is set to be completed by July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,373.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAAFDelivery Order
The Defense Logistics Agency awarded a $10,907.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on October 14, 2025, with completion targeted for October 15, 2025. This non-competitive delivery order will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a small transaction within the broader pharmaceutical supply relationship between AmerisourceBergen and the federal government's medical procurement system. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. NURTEC ODT is a migraine treatment medication, consistent with the contractor's extensive portfolio of brand-name and generic pharmaceuticals across multiple therapeutic domains. The firm fixed price delivery order structure provides predictable costs while leveraging the established framework of the larger IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 10/14/25 |